IRVINE, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Praxsyn Corporation (OTCQB:PXYN) is pleased to announce that its wholly owned subsidiary Mesa Pharmacy has begun accepting prescriptions for personal injury patients.
This new area of business is part of Mesa Pharmacy’s overall growth strategy to expand into new markets and new geographical locations. Mesa Pharmacy is continuing to build sales on a national level and reach beyond the workers compensation space.
Greg Sundem, the company’s Chief Executive Officer stated, “Patients need easy access to prescription medications when they have been injured, and we intend on filling that gap when there is such a need. Our goal is to build a solid foundation, shipping to several states, accepting different types of cases, and holding more of the accounts receivable that are generated by the new line of business to provide an overall higher profit margin."
Personal injury cases are an exciting expansion for Mesa Pharmacy, it is estimated that there are over 300,000 injury automobile accident cases in California alone, and over 3,000,000 nationally. With over 30 million injury cases across the United States each year, including automobile accident injuries, slip and fall injuries, and work related injuries, Mesa Pharmacy is looking to provide quality pharmacy services for those injured patients.
About Praxsyn Corporation
Headquartered in Irvine, California, Praxsyn works to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, a wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients. Additional company information can be found at www.praxsyn.com.
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding Mesa Pharmacy’s new line of business, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports we filed with the SEC.
Media/Investor Contact: IR@PraXsyn.com 949-777-6112 ext 101